Repetitive dextromethorphan at adolescence affects water maze learning in female rats

International Journal of Neuroscience

Volumn 116, Issue 2, 2006, Pages 91-101

  Hee, Jeong Cho ^a   Jae, Goo Kim ^a   Joo, Young Lee ^a   Lee, Seoul ^b   Jeong, Won Jahng ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Wonkwang University   (South Korea)

Author keywords

Adolescence; Drug abuse; Hippocampus; Memory; NMDA (N methyl D aspartate) receptor; Rats

Indexed keywords

DEXTROMETHORPHAN; WATER;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; FEMALE; HIPPOCAMPUS; LEARNING; LEARNING DISORDER; MALE; MAZE TEST; MEMORY; MEMORY DISORDER; NEUROLOGIC DISEASE; NONHUMAN; PERINATAL PERIOD; RAT; SEX DIFFERENCE; TASK PERFORMANCE;

AGE FACTORS; ANIMALS; DEXTROMETHORPHAN; DRUG ADMINISTRATION SCHEDULE; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; MALE; MAZE LEARNING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; REVERSAL LEARNING; SEX FACTORS;

EID: 30344442454     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.1080/00207450500341415     Document Type: Article

References (25)

1. Bane, A., Rojas, D., Indermaur, K., Bennett, T., & Avery, D. (1996). Adverse effects of dextromethorphan on the spatial learning of rats in the Morris water maze. European Journal of Pharmacology, 302, 7-12.
2. Bem, J. L., & Peck, R. (1992). Dextromethorphan. An overview of safety issues. Drug Safety, 7, 190-199.
3. Butelman, E. R. (1989). A novel NMDA antagonist, MK-801, impairs performance in a hippocampal-dependent spatial learning task. Pharmacology Biochemistry & Behavior, 34, 13-16.
4. Chase, T. N., Oh, J. D., & Konitsiotis, S. (2000) Antiparkinsonian and antidyskinetic activity of drugs targeting central glutamatergic mechanisms. Journal of Neurology, 247(Suppl 2), 1136-1142.
5. Darboe, M. N., Keenan, G. R. Jr., & Richards, T. K. (1996). The abuse of dextromethorphan-based cough syrup: A pilot study of the community of Waynesboro, Pennsylvania. Adolescence, 31, 633-644.
6. Dingledine, R., Borges, K., Bowie, D., & Traynelis, S. F. (1999). The glutamate receptor ion channels. Pharamcological Reviews, 51, 7-61.
7. Fisher, K., Coderre, T. J., & Hagen, N. A. (2000). Targeting the N-methyl-D-aspartate receptor for chronic pain management. Preclinical animal studies, recent clinical experience and future research directions. Journal of Pain Symptom Management, 20, 358-373.
8. Gorter, J. A., & de Bruin, J. P. C. (1992). Chronic neonatal MK-801 treatment results in an impairment of spatial learning in the adult rat. Brain Research, 580, 12-17.
9. Holtzman, S. G. (1982). Phencyclidine-like discriminative stimulus properties of opioids in the squirrel monkey. Psychopharmacology, 77, 295-300.
10. Jahng, J. W., Zhang, T. Y., Lee, S., & Kim, D. G. (2001). Effects of dextromethorphan on the nocturnal behavior and brain c-Fos expressions in adolescent rats. European Journal of Pharmacology, 431, 47-52.
11. McEwen, B. (2002). Estrogen actions throughout the brain. Recent Progress in Hormonal Research, 57, 357-384.
12. Murray, S., & Brewerton, T. (1993). Abuse of over-the-counter dextromethorphan by teenagers. Southern Medical Journal, 86, 1151-1153.
13. Noonan, W. C., Miller, W. R., & Feeney, D. M. (2000). Dextromethorphan abuse among youth. Archives of Family Medicine, 9, 791-792.
14. Price, D. D., Mao, J., Lu, J., Caruso, F. S., Frenk, H., & Mayer, D. J. (1996). Effects of the combined oral administration of NSAIDs and dextromethorphan on behavioral symptoms indicative of arthritic pain in rats. Pain, 68, 119-127.
15. Price, L. H., & Lebel, J. (2000). Dextromethorphan-induced psychosis. American Journal of Psychiatry, 157, 304.
16. Sagratella, S. (1995). NMDA antagonists: Antiepileptic-neuroprotective drugs with diversified neuropharmacological profiles. Pharmacological Research, 32, 1-13.
17. Sircar, R. (2003). Postnatal phencyclidine-induced deficit in adult water maze performance is associated with N-methyl-D-aspartate receptor upregulation. International Journal of Developmental Neuroscience, 21, 159-167.
18. Steinberg, G. K., Kunis, D., DeLaPaz, R., & Poljak, A. (1993). Neuroprotection following focal cerebral ischaemia with the NMDA antagonist dextromethorphan has a favourable dose response profile. Neurological Research, 15, 174-80.
19. Venable, N., & Kelly, P. H. (1991). Effects of NMDA antagonists on memory processes in a novel two-trial swimming test. Behavioral Pharmacology, 2, 161-169.
20. Weinbroum, A. A., Rudick, V., Paret, G., & Ben-Abraham, R. (2000). The role of dextromethorphan in pain control. Canadian Journal of Anaesthesia, 47, 585-596.
21. Willets, J., Balster, R. L., & Leander, J. D. (1990). The behavioral pharmacology of NMDA receptor antagonists. Trends in Pharmacological Sciences, 11, 423-428.
22. Wolfe, T. R., & Caravati, E. M. (1995). Massive dextromethorphan ingestion and abuse. American Journal of Emergency Medicine, 13, 174-176.
23. Ylinen, A., Pitkanen, M., Sirvio, J., Hartikainen, T., Sivenius, J., Koivisto, E., & Riekkinen, P. J. Jr. (1995). The effects of NMDA receptor antagonists at anticonvulsive doses on the performance of rats in the water maze task. European Journal of Pharmacology, 274, 159-165.
24. Zhang, T. Y., Jahng, J. W., Kim, E. J., Chung, H., & Kim, D. G. (1999). Chronic dextromethorphan increases NMDAR1 immunoreactivity in the brain and induces sensitization of stereotyped behavior in female rats. Society for Neuroscience Abstract, 25, 2077.
25. Zhang, T. Y., Jahng, J. W., & Kim, D. G. (2001). Dextromethorphan increases tyrosine hydroxylase mRNA in the mesencephalon of adolescent rats. Neuroscience Letters, 309, 85-88.